Clinical Trial Update: RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating progesterone to prevent preterm birth in nulliparous women with a short cervix; study terminated with results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Insufficiency
• Preterm Birth

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: The George Washington University Biostatistics Center | Conditions: Preterm Delivery, Cervical Length | Phase 3 | Status: TERMINATED | Results posted: 2019-04-11